Genomics Collaborative Overview

  • Founded
  • 1998
Founded
  • Status
  • Acquired/​Merged
  • Employees
  • 35
Employees
  • Latest Deal Type
  • M&A
  • Latest Deal Amount
  • $14.3M
Latest Deal Amount

Genomics Collaborative General Information

Description

Developer of an integrated discovery platform to transform the next stage of genomic and proteomic discovery. The company provides clinical samples and develops methods for application of human genetics to target validation for drug discovery. It offers GCI platforms including GCI Discovery and Global Repository which would help in expediting drug discovery and improvements in diagnosis, prediction, prevention, and treatment of disease.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Other Pharmaceuticals and Biotechnology
Biotechnology
Primary Office
  • 99 Erie Street
  • Cambridge, MA 02139
  • United States
+1 (617) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Genomics Collaborative Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Merger/Acquisition 03-Jun-2004 $14.3M 000.00 000.00 Completed Pre-Clinical Trials
5. Later Stage VC (Series E) 11-Nov-2002 00.00 000.00 000.00 Completed Pre-Clinical Trials
4. Later Stage VC (Series D) 12-Oct-2000 000.00 000.00 00000 Completed Product Development
3. Later Stage VC (Series C) 000.00 000.00 000.00 Completed
2. Early Stage VC (Series B) $2.2M $4.2M 000.00 Completed
1. Early Stage VC (Series A) $2M $2M 000.00 Completed Product Development
To view Genomics Collaborative’s complete valuation and funding history, request access »

Genomics Collaborative Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series E 00,000,000 00.000000 00 00.00 00.00 00 00.00 00.000
Series D 00,000,000 00.000000 00 00 00 00 00 00.000
Series C 00,000,000 00.000000 00 00.00 00.00 00 00.00 0.000
Series B 1,543,225 $0.010000 9% $1.43 $0.11 0x $1.43 1.33%
Series A 4,200,000 $0.010000 9% $0.48 $0.08 0x $0.48 3.61%
To view Genomics Collaborative’s complete cap table history, request access »

Genomics Collaborative Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Genomics Collaborative Former Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Flagship Pioneering Venture Capital Minority 000 0000 000000 0
Invesco Asset Manager Minority 000 0000 000000 0
Oracle Capital Partners PE/Buyout Minority 000 0000 000000 0
Singapore Economic Development Board Government Minority 000 0000 000000 0
Whitney & Company Other Minority 000 0000 000000 0
To view Genomics Collaborative’s complete investors history, request access »